Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Novartis N Ord (0QLR) Share Price

Price 127.63 on 20-02-2026 at 05:12:27
Change 0.00 0%
Buy 130.82
Sell 124.44
Last Trade: Unknown 25.00 at 128.00192
Day's Volume: 0
Last Close: 127.63
Open: 0.00
ISIN: CH0012005267
Day's Range 0.00 - 0.00
52wk Range: 81.23 - 128.94
Market Capitalisation: -
VWAP: 0.00
Shares in Issue: 1.91b

Novartis N Ord (0QLR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 25 128.00192 OTC Trade
18:28:19 - 19-Feb-26
Unknown* 1,000 128.04 Negotiated Trade
OTC Trade
18:17:26 - 19-Feb-26
Unknown* 4,667 126.47353 OTC Trade
18:12:12 - 19-Feb-26
Unknown* 22,500 126.74256 OTC Trade
17:46:56 - 19-Feb-26
Unknown* 2,200 127.99 SI Trade
17:45:44 - 19-Feb-26
Unknown* 512 127.05637 SI Trade
Negotiated Trade
17:34:16 - 19-Feb-26
Unknown* 5,000 126.46934 OTC Trade
17:22:53 - 19-Feb-26
Unknown* 7,200 127.50 OTC Trade
17:22:16 - 19-Feb-26
Unknown* 370 127.38246 OTC Trade
17:15:33 - 19-Feb-26
Unknown* 3,238 126.79482 OTC Trade
17:10:52 - 19-Feb-26
See more Novartis N Ord trades

Novartis N Ord (0QLR) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Feb 2026 (Fri) 127.63 127.63 127.63 127.63 0
19th Feb 2026 (Thu) 128.06 128.06 124.86 127.63 1,322,148
18th Feb 2026 (Wed) 128.59 128.73 125.38 128.73 6,003,584
17th Feb 2026 (Tue) 126.78 128.94 123.62 128.94 906,082
16th Feb 2026 (Mon) 124.84 124.88 121.72 124.88 402,417
13th Feb 2026 (Fri) 124.36 124.36 121.26 124.20 1,084,038
12th Feb 2026 (Thu) 122.85 122.87 119.78 122.87 774,093
11th Feb 2026 (Wed) 121.16 123.15 118.14 123.15 1,291,400
10th Feb 2026 (Tue) 120.36 120.36 117.36 120.06 2,182,797
9th Feb 2026 (Mon) 120.73 120.82 117.72 120.82 770,750
6th Feb 2026 (Fri) 118.93 120.36 115.96 120.36 1,670,903
5th Feb 2026 (Thu) 117.76 119.54 114.82 119.54 806,019
4th Feb 2026 (Wed) 114.81 119.42 111.94 119.42 1,353,348
3rd Feb 2026 (Tue) 117.27 117.45 114.34 117.45 579,820
2nd Feb 2026 (Mon) 114.81 116.73 111.94 116.73 1,605,050
30th Jan 2026 (Fri) 113.98 113.98 111.14 113.98 503,055
29th Jan 2026 (Thu) 112.98 113.14 110.16 113.14 447,333
28th Jan 2026 (Wed) 115.67 115.67 112.78 113.80 877,741
27th Jan 2026 (Tue) 115.44 115.73 112.56 115.73 494,036
26th Jan 2026 (Mon) 115.46 115.58 112.58 115.58 775,913
23rd Jan 2026 (Fri) 114.76 115.01 111.90 115.01 1,432,632
22nd Jan 2026 (Thu) 114.17 114.33 111.32 114.33 493,468
21st Jan 2026 (Wed) 114.44 114.52 111.58 114.52 1,580,770
20th Jan 2026 (Tue) 114.54 114.54 111.68 114.27 336,356
See more Novartis N Ord price history

Novartis N Ord (0QLR) Share News

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

24th Jul 2019 10:34

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a Read More

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

1st Jul 2019 09:13

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replacing Philip Richards, who will retire in Read More

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

24th May 2019 09:35

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU Read More

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

26th Mar 2019 12:07

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in Japan.Oxford BioMedica is the sole of in Read More

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

20th Feb 2019 10:25

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight Abbreviated New Drug Applications from Sandoz a Read More

See more Novartis N Ord news
FTSE 100 Latest
Value10,627.04
Change-59.14

Login to your account

Forgot Password?

Not Registered